# Effect of Ultra-gyn® on Vulvovaginal Candidiasis

> **NCT05273333** · NA · UNKNOWN · sponsor: **Biocodex** · enrollment: 30 (estimated)

## Conditions studied

- Vulvovaginal Candidiasis, Genital

## Interventions

- **DEVICE:** Ultra-gyn®

## Key facts

- **NCT ID:** NCT05273333
- **Lead sponsor:** Biocodex
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-23
- **Primary completion:** 2022-07
- **Final completion:** 2022-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05273333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05273333, "Effect of Ultra-gyn® on Vulvovaginal Candidiasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05273333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*